B. Riley upgraded shares of ZimVie (NASDAQ:ZIMV – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday,Zacks.com reports.
Separately, Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research report on Wednesday.
Read Our Latest Report on ZimVie
ZimVie Price Performance
ZimVie (NASDAQ:ZIMV – Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. The business had revenue of $111.52 million during the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. On average, analysts forecast that ZimVie will post 0.6 EPS for the current year.
Institutional Trading of ZimVie
A number of institutional investors have recently added to or reduced their stakes in ZIMV. SG Americas Securities LLC grew its stake in shares of ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock valued at $155,000 after buying an additional 1,508 shares in the last quarter. EMC Capital Management boosted its holdings in ZimVie by 47.0% in the 4th quarter. EMC Capital Management now owns 13,802 shares of the company’s stock worth $193,000 after acquiring an additional 4,414 shares during the period. Wealth Enhancement Advisory Services LLC raised its stake in shares of ZimVie by 5.8% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company’s stock valued at $211,000 after purchasing an additional 836 shares during the period. Wells Fargo & Company MN raised its stake in shares of ZimVie by 17.8% during the fourth quarter. Wells Fargo & Company MN now owns 17,037 shares of the company’s stock valued at $238,000 after purchasing an additional 2,569 shares during the period. Finally, Principal Financial Group Inc. purchased a new position in shares of ZimVie in the third quarter valued at $275,000. 95.63% of the stock is owned by hedge funds and other institutional investors.
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Read More
- Five stocks we like better than ZimVie
- What Are Dividend Contenders? Investing in Dividend Contenders
- JPMorgan is a Buy, if You Can Handle The Volatility
- EV Stocks and How to Profit from Them
- United States Steel’s Crash: An Unmissable Buying Opportunity
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.